Why the pharmacy matters more than the website
For the 2026 enforcement record on both pharmacy types (the September 18, 2026 Empower warning letter under 503A and the April 30, 2026 proposal to keep semaglutide off the 503B bulks list), see is compounded semaglutide going away?
Our top 2 picks
Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.
Exceptional
Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery
Treatments offered
Compounded semaglutide injections (GLP-1), not FDA-approved · Compounded tirzepatide injections (dual GIP/GLP-1), not FDA-approved · Online intake and prescriber review by OpenLoop Health clinicians · Transfer at your current dose with proof of your existing prescription
Starting price
$49/month
*Compounded medications are not FDA-approved.
- Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
- Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
- Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
- No insurance required, no clinic visits; cancel at least 72 hours before the next billing date
from $49/month
Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.
Read full embody reviewExcellent
Most Comprehensive GLP-1 Medication Access
Treatments offered
Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Brand-name Zepbound and Wegovy · One simple injection per week
Starting price
$199$89/month
*Compounded medications are not FDA-approved.
- Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
- Brand-name options too: Zepbound and Wegovy
- Clinician-guided - physician, PA, or nurse practitioner
- Free shipping (about 5-7 days)
from $89/month
Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.
Read full altRx reviewWhat is a 503A pharmacy?
What is a 503B outsourcing facility?
Section 503B, added in 2013, created a second category: outsourcing facilities that register with the FDA, are inspected by the FDA, and must follow current good manufacturing practice - the same quality framework as drug manufacturers. In exchange they can compound larger batches without a prescription for each patient, typically to supply hospitals and clinics.
During the 2022-2024 shortages of semaglutide and tirzepatide, both 503A pharmacies and 503B facilities were permitted to compound them, which is how the market of compounded GLP-1s grew so quickly. Neither category makes an FDA-approved drug: a 503B facility's product is made under manufacturing standards, but it is still a compounded product with no trials of its own.
Shop GLP-1 plans by product
The lowest published plans - cheapest first, conditions under each price.
What changed when the shortages ended?
The FDA removed tirzepatide and then semaglutide from its shortage list between late 2024 and early 2025, and with that the exemption that allowed compounding of "essentially a copy" of a commercially available drug closed. The standard rules apply again: compounding has to be for a specific patient on a valid prescription, with a clinical reason, through a 503A pharmacy - not bulk production of a copy of Wegovy or Zepbound.
The FDA has followed up on the marketing side: warning letters to telehealth companies in 2026 objected to products described as "generic" Ozempic or Wegovy, as containing "the same active ingredient as" the brand drug, or as coming from an "FDA-approved pharmacy" - the FDA approves drugs, not pharmacies. If a provider's page uses that language, it is a signal about the provider, whatever the pharmacy.
The honest framing is in compounded vs brand-name.
What To Know Before Starting GLP-1 Treatment
Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.
GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.
That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

What is the 28-day rule?
Compounded GLP-1 injections are usually dispensed as a multi-dose vial you draw from weekly. Sterile-compounding standards assign every such preparation a beyond-use date - the point after which it should not be used - and for an opened multi-dose vial the conventional limit is 28 days from first puncture, which is why experienced buyers talk about "the 28-day rule".
Two practical consequences. First, this is why legitimate plans ship every four weeks: a vial sized for a month matches the rule.
One captured welludr reviewer's complaint title was simply "They charge you every 21 days" - billing cadence and the vial's use period are worth matching up before you sign. Second, a vial sold as a three-month supply to draw from across 90 days is a warning sign, not a bargain.
The beyond-use date should be printed on the label; if it isn't, ask the pharmacy, not the provider.
The questions that separate a legitimate operation
Four, all with checkable answers. Which pharmacy fills my prescription, and in which state is it licensed? A legitimate provider names it; you can verify the licence on that state board's website. Is it 503A or 503B? Either can be legitimate; evasion is the warning sign. What is the beyond-use date on the vial, and how is it shipped? Cold-chain shipping with a dated label is the standard; our provider comparison records what each provider promises. Who decides my dose? "A licensed clinician reviews your history and prescribes" is the right answer; "guaranteed approval" is the wrong one. Providers that pass all four are in our verified ranking, and the ones we have examined most closely are written up in is embody legit and is welludr legit.
What no pharmacy can supply is an unapproved "research peptide" sold without a prescription; that is a different market entirely. This article is general information about how compounding is regulated; a licensed clinician decides whether any treatment is appropriate for you.









